UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): ~~June~~July 295, 2022 (~~June~~July 295, 2022)

HEALTHCARE REALTY TRUST INCORPORATED

(Exact Name of Registrant as Specified in Charter)

Maryland

001-11852

62-1507028

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer
Identification No.)

3310 West End Avenue, Suite 700

Nashville, Tennessee 37203

(Address of principal executive offices)

(615) 269-8175

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)


Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol	Name of each exchange on which registered
Common stock, $0.01 par value per share	HR	New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

Dividend Press Release

On July 1, 2022, Healthcare Realty Trust Incorporated (the "Company") issued a press release announcing a pro-rated quarterly dividend. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

Item 8.01 Other Events

On ~~June~~July 295, 2022, ~~Healthcare Realty Trust Incorporated (~~the “Company”) ~~and Healthcare Trust of America, Inc. (“HTA”)~~ issued a ~~joint~~ press release announcing ~~the results of early participation in the exchange offers and consent solicitations~~ that ~~HTA~~independent ~~and~~proxy ~~its~~advisory ~~operating~~firm ~~partnership,~~Institutional ~~Healthcare~~Shareholder ~~Trust~~Services ~~of America Holdings, LP~~ (“~~HTA OP~~ISS”), ~~commenced~~recommends onthat ~~June 14, 2022 to exchange all validly tendered and accepted notes issued by~~ the Company's ~~for~~shareholders ~~new~~vote ~~notes~~“FOR” tothe bepreviously ~~issued~~announced bytransaction ~~HTA~~with OPHealthcare ~~and~~Trust ~~guaranteed~~of byAmerica, ~~HTA~~Inc. (~~the~~ “~~Exchange Offer~~HTA”). Aat ~~Registration Statement on Form S-4 relating to~~ the ~~Exchange~~Company’s ~~Offer~~upcoming ~~was~~special ~~filed~~meeting byof ~~HTA~~shareholders ~~with~~scheduled ~~the~~for ~~Securities~~July ~~and Exchange Commission (the "SEC") on June 14~~15, 2022 ~~and was declared effective on June 28, 2022~~. A copy of ~~the~~this ~~joint~~ press release is ~~filed~~furnished as Exhibit 99.12 ~~hereto~~to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

Important Additional Information and Where to Find It

In addition to the Exchange Offer, this communication relates to the proposed transaction pursuant to the terms of the definitive Agreement and Plan of Merger (the "Merger Agreement") entered into on February 28, 2022 by the Company, HTA, HTA OP, and HR Acquisition 2, LLC (the "Merger Sub") (the "Proposed Transaction"). In connection with the Proposed Transaction, HTA filed with the SEC a registration statement on Form S-4 that was declared effective on June 9, 2022 that includes a joint proxy statement of the Company and HTA and that also constitutes a prospectus of HTA. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT ON FORM S-4 AND THE RELATED JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS AND ANY OTHER RELEVANT DOCUMENTS TO BE FILED WITH THE SEC IN CONNECTION WITH THE PROPOSED TRANSACTION, BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, HTA, HTA OP, AND MERGER SUB AND THE PROPOSED TRANSACTION. Investors and security holders may obtain copies of these documents free of charge through the website maintained by the SEC at www.sec.gov or from the Company at its website, www.healthcarerealty.com, or from HTA at its website, www.htareit.com. Documents filed with the SEC by the Company will be available free of charge by accessing the Company’s website at www.healthcarerealty.com under the heading Investor Relations or, alternatively, by directing a request to the Company at communications@healthcarerealty.com or 3310 West End Avenue, Suite 700, Nashville, Tennessee 37203, telephone: (615) 269-8175, and documents filed with the SEC by HTA will be available free of charge by accessing HTA’s’ website at www.htareit.com under the heading Investor Relations or, alternatively, by directing a request to HTA at info@htareit.com or 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona 85254, telephone (480) 998-3478.

Participants in the Solicitation

The Company and HTA and certain of their respective directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies from the common shareholders of the Company and HTA in respect of the proposed transaction under the rules of the SEC. Information about the Company’s directors and executive officers is available in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on February 22, 2022, and definitive proxy statement dated March 25, 2022 for its 2022 annual meeting of shareholders. Information about HTA’s directors and executive officers is available in HTA’s Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 1, 2022 as amended by Amendment No. 1 on Form 10-K/A filed with the SEC on April 12, 2022. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are contained in the joint proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Proposed Transaction if and when they become available. Investors should read the joint proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions. You may obtain free copies of these documents from the Company or HTA using the sources indicated above.

No Offer or Solicitation

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.

Item 9.01 Financial Statements and Exhibits

99.1 ~~Press~~Dividend ~~Release~~press release, dated ~~June~~July 291, 2022.

99 .2 Press release, dated July 5, 2022.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HEALTHCARE REALTY TRUST INCORPORATED
	By:	/s/ J. Christopher Douglas
		J. Christopher Douglas
		Executive Vice President - Chief Financial Officer
June 29, 2022
July 5, 2022

Filing Compare · HRTI, LLC